Publication details

Lapatinib v léčbě pokročilého karcinomu prsu

Title in English Lapatinib in the treatment of advanced breast cancer
Authors

ABRAHÁMOVÁ J. DUŠEK Ladislav BRABEC Petr VYZULA R. DONÁTOVÁ Z.

Year of publication 2011
Type Article in Periodical
Magazine / Source Praktický lékař
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords lapatinib; ErbB2(HER2); advanced breast cancer; Czech drug registry
Description The authors present data from the Czech drug registry concerning the use of lapatinib in combination with capecitabine in advanced breast cancer patients, whose tumours highly express ErbB2 (HER2). Despite patients’ substantial previous treatment we can demonstrate the efficacy of lapatinib; the Czech data is comparable to the results of the registration study.

You are running an old browser version. We recommend updating your browser to its latest version.

More info